has announced a $150 million commitment — the largest in its history — from board member David H. Koch.
The gift, which also is the largest single donation ever made by Koch, will support construction of a $1.3 billion, 750,000-square-foot outpatient medical facility to be known as the . Currently under development and scheduled to open in 2019, the new facility will offer clinical trials not typically available at other area hospitals as well as a pioneering outpatient bone marrow transplant unit which will perform procedures that in the past required strict isolation and a lengthy hospital stay. Also located in the building will be MSK's full array of diagnostic and therapeutic services, as well as programs for patients with lung, head and neck, and hematologic cancers.
An MSK board member since 1990, Koch has now given a total of $225 million to the hospital, including funds to establish the David H. Koch Center for the Immunologic Control of Cancer, endow two David H. Koch chairs, and provide ongoing support for prostate cancer research.
"The creation of this outstanding facility will be a real game changer for Memorial Sloan Kettering," said MSK president and CEO Craig B. Thompson. "Thanks to David's landmark commitment, we will be able to offer cutting-edge therapies and an expanded roster of innovative clinical trials to more patients than ever. The knowledge gained from the work conducted inside the David H. Koch Center for Cancer Care will benefit cancer patients around the world."